Stress T1 mapping and quantitative perfusion cardiovascular magnetic resonance in patients with suspected obstructive coronary artery disease

疑似阻塞性冠状动脉疾病患者的应激T1映射和定量灌注心血管磁共振成像

阅读:2

Abstract

AIMS: T1 mapping reactivity (ΔT1) has been proposed as a novel contrast-free technique to detect obstructive coronary artery disease (CAD). The aims of the study are: (i) to compare the cardiovascular magnetic resonance (CMR)-derived ΔT1 with quantitative perfusion (QP CMR) measures; (ii) to assess the influence of sex and comorbidities on ΔT1; and (iii) to assess the diagnostic accuracy of ΔT1 to detect obstructive CAD diagnosed with the invasive coronary angiography (ICA) and/or fractional flow reserve. METHODS AND RESULTS: This study retrospectively analysed 51 patients with suspected obstructive CAD who underwent CMR including rest and adenosine stress first-pass perfusion and native T1 mapping (MOLLI). A moderate correlation was found between pooled rest and stress native T1 mapping and myocardial blood flow (Pearson's r = 0.476; P < 0.001). When stratified by myocardial perfusion reserve (MPR), ischaemic myocardium had significantly lower stress T1 mapping values (P < 0.001) and ΔT1 (P = 0.005) vs. nonischaemic myocardium. Male sex and history of diabetes were independently associated with lower ΔT1. The optimal cut-off value of ΔT1 to detect impaired MPR on a per-vessel basis was ≤5.4%, with an area under the curve of 0.662 (95% CI: 0.563-0.752, P = 0.003), sensitivity of 84% (95% CI: 67-95), and specificity of 46% (95% CI: 34-58). When validated against ICA, stress T1 and ΔT1 did not reach statistical significance in detecting obstructive CAD. CONCLUSION: ΔT1 is significantly influenced by sex and comorbidities and has poor diagnostic accuracy for detecting myocardial ischaemia. Therefore, the clinical utility of ΔT1 in a real-world cohort of patients to detect obstructive CAD is limited.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。